targeting vegf-b novel treatment insulin resistance type diabetes 
prevalence type diabetes rapidly increasing severe socioeconomic impacts12 excess lipid deposition peripheral tissues impairs insulin sensitivity glucose uptake proposed contribute pathology type diabetes3- however treatment options exist directly target ectopic lipid accumulation6 recently found vascular endothelial growth factor b vegf-b controls endothelial uptake transport fatty acids heart skeletal muscle7 show decreased vegf-b signalling rodent models type diabetes restores insulin sensitivity improves glucose tolerance genetic deletion vegfb diabetic db/db mice prevented ectopic lipid deposition increased-muscle glucose uptake maintained normoglycaemia pharmacological inhibition vegf-b signalling antibody administration db/db mice enhanced glucose tolerance preserved pancreatic islet architecture improved beta-cell function ameliorated dyslipidaemia key elements type diabetes metabolic syndrome potential use vegf-b neutralization type diabetes elucidated rats fed high-fat diet normalized insulin sensitivity increased glucose uptake skeletal muscle heart results demonstrate vascular endothelium can function efficient barrier excess muscle lipid uptake even conditions severe obesity type diabetes barrier can maintained inhibition vegf-b signalling propose vegf-b antagonism novel pharmacological approach type diabetes targeting lipid-transport properties endothelium improve muscle insulin sensitivity glucose disposal 
